Company Overview
- Headquarters
- 400 Alexander Park Drive 4th Floor, Princeton NJ
- Website
- urogen.com
- Phone
- (646) 768-9780
- Employees
- 255
- Founded in
- 2004
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:URG
Financials & Stats
Revenue
$50B
Who is UroGen Pharma
UroGen Pharma is a biotechnology company based in Princeton, New Jersey. The company employs 255 people and generates $50 million in annual revenue. UroGen Pharma focuses on developing novel solutions to treat specialty cancers and urologic diseases. Their core technology, RTGel®, is a reverse-thermal hydrogel that acts as a drug delivery system. This technology converts from a liquid to a gel at body temperature, potentially improving the effectiveness of local therapies. The company's product pipeline includes multiple candidates in various stages of development, ranging from pre-clinical to Phase 3, exploring potential treatments in urology, uro-oncology, and immunology. UroGen Pharma emphasizes its collaborative approach to research and development. The company actively seeks partnerships to advance its mission of improving patient care and exploring new treatment pathways. For more information, please visit UroGen Pharma's website at urogen.com.
Company Leadership
Companies Similar to UroGen Pharma
Analyze industry trends and opportunities by examining competitors and companies comparable to UroGen Pharma, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |